Your mission
The Josep Carreras Leukemia Research Institute (IJC) is a comprehensive cancer research center dedicated to researching and promoting innovation in the epidemiological, preventive, clinical, translational and basic aspects of leukemia and other hematological neoplasms, with the objective end of finding a cure for these diseases. It was created in 2010, and since then it has experienced exponential growth.
The IJC is also part of the network of Research Centers of Excellence of Catalonia (CERCA) and was accredited as a Severo Ochoa Center of Excellence by the Ministry of Science, Innovation and Universities in 2024. Since 2018, the Institute has also been accredited by the Scientific Foundation of the Spanish Association Against Cancer (FCAECC) In addition, the IJC is one of the centers integrated into the accreditation of the Germans Trias i Pujol Research Institute (IGTP) as an Accredited Health Research Institute (IIS) by the Health Institute Charles III (ISCIII).
The main headquarters of the IJC is located within the Can Ruti Biomedical Campus, together with other leading biomedical institutions, providing direct access to cutting-edge scientific and technological facilities, as well as complementary community services. The IJC has six headquarters integrated into reference hospitals: Hospital Germans Trias i Pujol, Hospital Clínic, Hospital Sant Pau, Hospital Trueta, Hospital del Mar and Hospital San Joan de Déu. This facilitates close collaboration between basic and clinical researchers, fostering translational research that integrates basic science with clinical practice in clinical settings.
Research Description
The Chromatin Biology Laboratory led by Alex Vaquero is recognized for its expertise in studying response mechanisms under stress conditions. The group's main objective is to define the role of the sirtuin family of enzymes in regulating genome stability and epigenetics in response to stress, and their impact on cancer, senescence, and aging. Given the key role of cell senescence in both hematological and non-hematological cancers, understanding the underlying mechanisms driving cell senescence is crucial for comprehending its contribution to carcinogenesis and for the future design of novel anti-cancer therapies. Although sirtuins play an important role in regulating cell senescence in response to stress conditions, which impacts systemic aging, the mechanisms involved remain incompletely characterized. The project aims to study the functional link between Sirtuins and cell senescence by studying: 1) The regulation of the interferon signaling pathway, and 2) Identification and subsequent characterization of factors involved in the sirtuin-dependent regulation of cell senescence through functional screening.
Please also visit our group webpage: https://www.carrerasresearch.org/en/research/chromatin-biology-laboratory
https://www.sirtuinbiology.com/
MAIN RESPONSIBILITIES
- Study the role of Sirtuins in stress response and genome stability through a combination of biochemistry, molecular biology, genomics, proteomics and cell biology.
- Analyze the contribution of Sirtuins to Interferon signaling and its impact on cancer.
- Characterize the functional contribution of sirtuin to cell senescence and systemic aging.
- Analyze the role of sirtuin to heterogeneity in pro-inflammatory phenotype of cellular senescence through cell biology and multiomic analysis.